✦ LIBER ✦

Chemoprevention for prostate cancer

✍ Scribed by Michael K. Brawer; William J. Ellis

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 691 KB
Volume: 75
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19950401)75:7+<1783::aid-cncr2820751606>3.0.co;2-u

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemoprevention of prostate cancer: The

Chemoprevention of prostate cancer: The prostate cancer prevention trial

✍ Thompson, Ian M.; Coltman, Charles A.; Crowley, John 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 2 views

## BACKGROUND. A variety of innovative approaches to the prevention of prostate cancer are now available, including selenium, alpha tocopherol, dietary interventions, and vitamin D. Perhaps the most promising opportunity is based upon considerable evidence that cumulative androgen exposure of the

Chemoprevention of prostate cancer: Guid

Chemoprevention of prostate cancer: Guidelines for possible intervention strategies

✍ E. David Crawford; William R. Fair; Gary J. Kelloff; Michael M. Lieber; Gary J. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

The "natural history" of prostate cancer may bedevil the development of guidelines for chemoprevention interventions. Can strategies be designed to direct agents to those lesions which have the potential to develop localized extension that may become symptomatic or metastatic disease? Of necessity o

Introductory remarks: Development of che

Introductory remarks: Development of chemopreventive agents for prostate cancer

✍ Gary J. Kelloff; Charles W. Boone; Winfred F. Malone; Vernon E. Steele; Linda A. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 699 KB

The term "cancer chemoprevention" refers to the prevention of cancer by intervening with drugs prior to the malignant ( k . , invasive) stage of carcinogenesis. The development of chemopreventive drugs is the major objective of the Chemoprevention Branch at the National Cancer Institute. The testin

Prostate cancer chemoprevention by silib

Prostate cancer chemoprevention by silibinin: Bench to bedside

✍ Rana P. Singh; Rajesh Agarwal 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

## Abstract Prostate cancer (PCA) is the most invasive malignancy and second leading cause of cancer deaths in American males. One approach to reduce PCA incidence, growth and metastasis is prevention and intervention targeted towards mitogenic and survival signaling and cell‐cycle regulation. This

The role of prostate-specific antigen in

The role of prostate-specific antigen in the chemoprevention of prostate cancer

✍ E. David Crawford; Edward P. DeAntoni; Colleen A. Ross 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 691 KB

An understanding of the natural history of changes in prostate-specific antigen (PSA) may be valuable as a surrogate view of prostate dynamics, as a method to differentiate between benign and malignant growth, and as a means to assess the use of PSA as a tool for monitoring activity of chemopreventi

Mechanisms of selenium chemoprevention a

Mechanisms of selenium chemoprevention and therapy in prostate cancer

✍ Nagalakshmi Nadiminty; Allen C. Gao 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 1 views

## Abstract Prostate cancer (PC) chemoprevention has generated considerable interest in the last decade and selenium and combinations of selenium have been recognized as one of the most efficacious chemopreventive agents against PC. This review focuses on a discussion of the knowledge hitherto gain